Schedule 13D ownership disclosure

TEVA PHARMACEUTICAL INDS LTD

Security class unavailable · CUSIP: 881624209

Event date: 2018-01-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-009269
Form type
SC 13D/A
Filer
Allergan plc
CIK
CIK 1578845
Filed
Jan 12, 2018
Reporting period
Jan 10, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub